Drug Discovery: What's the difference between structure based and ligand based virtual screening?

OpenEye Helps Beacon Discovery Increase Speed and Improve Activity in Virtual ScreeningSee more

OpenEye Helps Beacon Discovery Increase Speed and Improve Activity in Virtual Screening

Challenges and approaches in ligand-based drug designSee more

Challenges and approaches in ligand-based drug design

Virtual screening Schrodinger Glide SARS COV Protein Zinc FDA DrugSee more

Virtual screening Schrodinger Glide SARS COV Protein Zinc FDA Drug

30th Series - Structure Based Drug DesignSee more

30th Series - Structure Based Drug Design

3D ligand based drug designSee more

3D ligand based drug design

Molecular Docking: A Pivotal Technique in Structure Based Drug Design | Speaker: Dr. Piyush GhodeSee more

Molecular Docking: A Pivotal Technique in Structure Based Drug Design | Speaker: Dr. Piyush Ghode

eSim3D: electrostatic field and surface-shape similarity for ligand-based drug designSee more

eSim3D: electrostatic field and surface-shape similarity for ligand-based drug design

Virtual Screening tech:Drug likeness screening, pharmacophore mapping& pharmacophore-based screeningSee more

Virtual Screening tech:Drug likeness screening, pharmacophore mapping& pharmacophore-based screening

35th Series - De novo drug design & Docking based ScreeningSee more

35th Series - De novo drug design & Docking based Screening

31st Series - Structure Based Drug DesignSee more

31st Series - Structure Based Drug Design

Computer Aided Drug Design (CADD)See more

Computer Aided Drug Design (CADD)

Structure based drug design - Case studySee more

Structure based drug design - Case study

Ligand-based drug targets & activity prediction tools/online servers@MajidAli2020See more

Ligand-based drug targets & activity prediction tools/online servers@MajidAli2020

Medicinal Chemistry III | Pharmacophore Modeling | AKTU Digital EducationSee more

Medicinal Chemistry III | Pharmacophore Modeling | AKTU Digital Education

Introduction into Fragment Based Drug DiscoverySee more

Introduction into Fragment Based Drug Discovery

Natural Language Processing for Drug Discovery: The State of Practices, Opportunities, & ChallengesSee more

Natural Language Processing for Drug Discovery: The State of Practices, Opportunities, & Challenges

Lecture-2 (11/1/2023): Virtual Screening & Drug development (Presented by Dr. Pradeep Natarajan)See more

Lecture-2 (11/1/2023): Virtual Screening & Drug development (Presented by Dr. Pradeep Natarajan)

MOE Virtual Screening | How to create Ligands Datasets | Lecture 84 | Dr. Muhammad NaveedSee more

MOE Virtual Screening | How to create Ligands Datasets | Lecture 84 | Dr. Muhammad Naveed

Drug Docking with Schrodinger (Spring 2022)See more

Drug Docking with Schrodinger (Spring 2022)

BAGIM Event: Structure and ligand-based analysis: combining the best of both worlds, 10/26/2021See more

BAGIM Event: Structure and ligand-based analysis: combining the best of both worlds, 10/26/2021

Actual